Skip to main content
IOL Chemicals & Pharmaceuticals Ltd logo

IOL Chemicals & Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · IOLCP ISIN · INE485C01029 LEI · 335800U5FXFDI8H3DT63 BSE.NS Manufacturing
Open in API
Filings indexed 1,007 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS IOLCP

About IOL Chemicals & Pharmaceuticals Ltd

https://www.iolcp.com/

IOL Chemicals and Pharmaceuticals Ltd is a manufacturer of Active Pharmaceutical Ingredients (APIs) and specialty chemicals. The company is the world's largest producer of Ibuprofen, maintaining a significant global market share through extensive vertical integration. Its pharmaceutical portfolio includes key therapeutic products such as Metformin, Fenofibrate, Clopidogrel, and Pantoprazole. In the specialty chemicals segment, it produces Ethyl Acetate, Iso Butyl Benzene, and Acetyl Chloride, catering to diverse industrial applications. The company operates advanced manufacturing facilities with international regulatory approvals, including the USFDA and EDQM. It focuses on cost-efficient production and sustainable practices to serve a global clientele across the pharmaceutical and chemical sectors.

Recent filings

Filing Released Lang Actions
Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q4 FY2026
Regulatory Filings Classification · 90% confidence The document is a routine SEBI Regulation 30 filing notifying stock exchanges of the audio recording link for the Q4 FY2026 analysts/investors call. It contains no financial statements, no transcript, and is merely a regulatory announcement. This does not constitute an earnings release, interim report, or call transcript. It falls under general regulatory announcements (RNS).
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 87% confidence The document is a regulatory disclosure under SEBI LODR Regulation 30 notifying stock exchanges of a schedule of investor/analyst meetings. It contains no financial statements, no investor presentation slides, no report attached, and is not announcing results or board changes. It is a mandatory regulatory announcement (general compliance disclosure), fitting the fallback category 'Regulatory Filings' (RNS).
2026-05-22 English
Schedule of Analyst/Investor Meeting
Regulatory Filings Classification · 86% confidence The document is a formal announcement to stock exchanges under SEBI LODR Regulation 30 outlining the schedule of upcoming analyst/institutional investor meetings. It does not contain financial statements, earnings figures, or board changes; nor is it a presentation itself. This type of disclosure falls under miscellaneous regulatory announcements to exchanges and is classified as a Regulatory Filing (RNS).
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter under SEBI LODR Regulation 30 providing a link to the audio recording of an analysts/investors call for Q4 FY2026. It neither contains financial data nor is the call transcript itself, but is a compliance announcement filed with the stock exchange. This fits the general “Regulatory Filings” category (RNS) rather than a financial report or transcript category.
2026-05-22 English
Investor Presentation
Investor Presentation Classification · 98% confidence The document is an investor slide deck titled “Investor Presentation-Q4 FY26” submitted under SEBI LODR Regulation 30. It contains detailed slides of quarterly and full‐year financial performance, segment overviews, balance sheet, cash flow, and business highlights for investors. This matches the Investor Presentation category.
2026-05-21 English
Investor Presentation
Investor Presentation Classification · 97% confidence The document is titled “Investor Presentation-Q4 FY26” and includes slide-style content: quarterly and annual financial highlights (P&L, balance sheet, cash flows), segment overviews, strategic and operational information, and corporate fact sheets. It is submitted under SEBI Listing Regulations as an investor presentation rather than a regulatory report. This matches the definition of an Investor Presentation (IP).
2026-05-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.